Prevenzione primaria della malattia cardiovascolare: c’è bisogno di un’aspirina?
The efficacy of antiplatelet treatment with aspirin in the primary prevention of major cardiovascular events was questioned during 2018, following a new series of trials that we summarize here in a quick synoptic overview. The three studies involved are the ASPREE trial, the ASCEND study and the ARR...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Italian |
| Published: |
AboutScience Srl
2019-09-01
|
| Series: | Giornale di Clinica Nefrologia e Dialisi |
| Online Access: | https://journals.aboutscience.eu/index.php/gcnd/article/view/535 |